SEC Form 4 · accession 0001213900-17-010350
RELMADA THERAPEUTICS, INC. · RLMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Paul Edward Kelly
Director
Period of report
Oct 4, 2017
Accepted (ET)
Oct 6, 2017 · 11:10 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001553643
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Convertible Note | $0.75 | Oct 4, 2017 | P | 200,000 | A | Oct 4, 2017 | Oct 4, 2019 | Common stock | 200,000 | 200,000 | D |
| Warrant | $1.50 | Oct 4, 2017 | P | 100,000 | A | Oct 4, 2017 | Oct 4, 2024 | Common stock | 100,000 | 100,000 | D |